Medical Care
Global Injectable Anthelmintic Drugs Market Research Report 2025
- Jun 28, 25
- ID: 346415
- Pages: 79
- Figures: 79
- Views: 1
The global market for Injectable Anthelmintic Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Injectable Anthelmintic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable Anthelmintic Drugs.
The Injectable Anthelmintic Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Injectable Anthelmintic Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Injectable Anthelmintic Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Cipla
Sun Pharmaceutical Industries
Amneal Pharmaceuticals
Zoetis
GlaxoSmithKline
Bayer
Merck
Boehringer Ingelheim International
Segment by Type
Benzimidazoles
Piperazine
Imidazothiazole
Spiroindoles
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Veterinary Pharmacies
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Injectable Anthelmintic Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Injectable Anthelmintic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable Anthelmintic Drugs.
The Injectable Anthelmintic Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Injectable Anthelmintic Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Injectable Anthelmintic Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Cipla
Sun Pharmaceutical Industries
Amneal Pharmaceuticals
Zoetis
GlaxoSmithKline
Bayer
Merck
Boehringer Ingelheim International
Segment by Type
Benzimidazoles
Piperazine
Imidazothiazole
Spiroindoles
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Veterinary Pharmacies
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Injectable Anthelmintic Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Injectable Anthelmintic Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Benzimidazoles
1.2.3 Piperazine
1.2.4 Imidazothiazole
1.2.5 Spiroindoles
1.2.6 Others
1.3 Market by Application
1.3.1 Global Injectable Anthelmintic Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Veterinary Pharmacies
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Injectable Anthelmintic Drugs Market Perspective (2020-2031)
2.2 Global Injectable Anthelmintic Drugs Growth Trends by Region
2.2.1 Global Injectable Anthelmintic Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Injectable Anthelmintic Drugs Historic Market Size by Region (2020-2025)
2.2.3 Injectable Anthelmintic Drugs Forecasted Market Size by Region (2026-2031)
2.3 Injectable Anthelmintic Drugs Market Dynamics
2.3.1 Injectable Anthelmintic Drugs Industry Trends
2.3.2 Injectable Anthelmintic Drugs Market Drivers
2.3.3 Injectable Anthelmintic Drugs Market Challenges
2.3.4 Injectable Anthelmintic Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Injectable Anthelmintic Drugs Players by Revenue
3.1.1 Global Top Injectable Anthelmintic Drugs Players by Revenue (2020-2025)
3.1.2 Global Injectable Anthelmintic Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Injectable Anthelmintic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Injectable Anthelmintic Drugs Revenue
3.4 Global Injectable Anthelmintic Drugs Market Concentration Ratio
3.4.1 Global Injectable Anthelmintic Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Injectable Anthelmintic Drugs Revenue in 2024
3.5 Global Key Players of Injectable Anthelmintic Drugs Head office and Area Served
3.6 Global Key Players of Injectable Anthelmintic Drugs, Product and Application
3.7 Global Key Players of Injectable Anthelmintic Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Injectable Anthelmintic Drugs Breakdown Data by Type
4.1 Global Injectable Anthelmintic Drugs Historic Market Size by Type (2020-2025)
4.2 Global Injectable Anthelmintic Drugs Forecasted Market Size by Type (2026-2031)
5 Injectable Anthelmintic Drugs Breakdown Data by Application
5.1 Global Injectable Anthelmintic Drugs Historic Market Size by Application (2020-2025)
5.2 Global Injectable Anthelmintic Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Injectable Anthelmintic Drugs Market Size (2020-2031)
6.2 North America Injectable Anthelmintic Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Injectable Anthelmintic Drugs Market Size by Country (2020-2025)
6.4 North America Injectable Anthelmintic Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Injectable Anthelmintic Drugs Market Size (2020-2031)
7.2 Europe Injectable Anthelmintic Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Injectable Anthelmintic Drugs Market Size by Country (2020-2025)
7.4 Europe Injectable Anthelmintic Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Injectable Anthelmintic Drugs Market Size (2020-2031)
8.2 Asia-Pacific Injectable Anthelmintic Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Injectable Anthelmintic Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Injectable Anthelmintic Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Injectable Anthelmintic Drugs Market Size (2020-2031)
9.2 Latin America Injectable Anthelmintic Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Injectable Anthelmintic Drugs Market Size by Country (2020-2025)
9.4 Latin America Injectable Anthelmintic Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Injectable Anthelmintic Drugs Market Size (2020-2031)
10.2 Middle East & Africa Injectable Anthelmintic Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Injectable Anthelmintic Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Injectable Anthelmintic Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Injectable Anthelmintic Drugs Introduction
11.1.4 Novartis Revenue in Injectable Anthelmintic Drugs Business (2020-2025)
11.1.5 Novartis Recent Development
11.2 Cipla
11.2.1 Cipla Company Details
11.2.2 Cipla Business Overview
11.2.3 Cipla Injectable Anthelmintic Drugs Introduction
11.2.4 Cipla Revenue in Injectable Anthelmintic Drugs Business (2020-2025)
11.2.5 Cipla Recent Development
11.3 Sun Pharmaceutical Industries
11.3.1 Sun Pharmaceutical Industries Company Details
11.3.2 Sun Pharmaceutical Industries Business Overview
11.3.3 Sun Pharmaceutical Industries Injectable Anthelmintic Drugs Introduction
11.3.4 Sun Pharmaceutical Industries Revenue in Injectable Anthelmintic Drugs Business (2020-2025)
11.3.5 Sun Pharmaceutical Industries Recent Development
11.4 Amneal Pharmaceuticals
11.4.1 Amneal Pharmaceuticals Company Details
11.4.2 Amneal Pharmaceuticals Business Overview
11.4.3 Amneal Pharmaceuticals Injectable Anthelmintic Drugs Introduction
11.4.4 Amneal Pharmaceuticals Revenue in Injectable Anthelmintic Drugs Business (2020-2025)
11.4.5 Amneal Pharmaceuticals Recent Development
11.5 Zoetis
11.5.1 Zoetis Company Details
11.5.2 Zoetis Business Overview
11.5.3 Zoetis Injectable Anthelmintic Drugs Introduction
11.5.4 Zoetis Revenue in Injectable Anthelmintic Drugs Business (2020-2025)
11.5.5 Zoetis Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Details
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline Injectable Anthelmintic Drugs Introduction
11.6.4 GlaxoSmithKline Revenue in Injectable Anthelmintic Drugs Business (2020-2025)
11.6.5 GlaxoSmithKline Recent Development
11.7 Bayer
11.7.1 Bayer Company Details
11.7.2 Bayer Business Overview
11.7.3 Bayer Injectable Anthelmintic Drugs Introduction
11.7.4 Bayer Revenue in Injectable Anthelmintic Drugs Business (2020-2025)
11.7.5 Bayer Recent Development
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Injectable Anthelmintic Drugs Introduction
11.8.4 Merck Revenue in Injectable Anthelmintic Drugs Business (2020-2025)
11.8.5 Merck Recent Development
11.9 Boehringer Ingelheim International
11.9.1 Boehringer Ingelheim International Company Details
11.9.2 Boehringer Ingelheim International Business Overview
11.9.3 Boehringer Ingelheim International Injectable Anthelmintic Drugs Introduction
11.9.4 Boehringer Ingelheim International Revenue in Injectable Anthelmintic Drugs Business (2020-2025)
11.9.5 Boehringer Ingelheim International Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Injectable Anthelmintic Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Benzimidazoles
1.2.3 Piperazine
1.2.4 Imidazothiazole
1.2.5 Spiroindoles
1.2.6 Others
1.3 Market by Application
1.3.1 Global Injectable Anthelmintic Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Veterinary Pharmacies
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Injectable Anthelmintic Drugs Market Perspective (2020-2031)
2.2 Global Injectable Anthelmintic Drugs Growth Trends by Region
2.2.1 Global Injectable Anthelmintic Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Injectable Anthelmintic Drugs Historic Market Size by Region (2020-2025)
2.2.3 Injectable Anthelmintic Drugs Forecasted Market Size by Region (2026-2031)
2.3 Injectable Anthelmintic Drugs Market Dynamics
2.3.1 Injectable Anthelmintic Drugs Industry Trends
2.3.2 Injectable Anthelmintic Drugs Market Drivers
2.3.3 Injectable Anthelmintic Drugs Market Challenges
2.3.4 Injectable Anthelmintic Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Injectable Anthelmintic Drugs Players by Revenue
3.1.1 Global Top Injectable Anthelmintic Drugs Players by Revenue (2020-2025)
3.1.2 Global Injectable Anthelmintic Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Injectable Anthelmintic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Injectable Anthelmintic Drugs Revenue
3.4 Global Injectable Anthelmintic Drugs Market Concentration Ratio
3.4.1 Global Injectable Anthelmintic Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Injectable Anthelmintic Drugs Revenue in 2024
3.5 Global Key Players of Injectable Anthelmintic Drugs Head office and Area Served
3.6 Global Key Players of Injectable Anthelmintic Drugs, Product and Application
3.7 Global Key Players of Injectable Anthelmintic Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Injectable Anthelmintic Drugs Breakdown Data by Type
4.1 Global Injectable Anthelmintic Drugs Historic Market Size by Type (2020-2025)
4.2 Global Injectable Anthelmintic Drugs Forecasted Market Size by Type (2026-2031)
5 Injectable Anthelmintic Drugs Breakdown Data by Application
5.1 Global Injectable Anthelmintic Drugs Historic Market Size by Application (2020-2025)
5.2 Global Injectable Anthelmintic Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Injectable Anthelmintic Drugs Market Size (2020-2031)
6.2 North America Injectable Anthelmintic Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Injectable Anthelmintic Drugs Market Size by Country (2020-2025)
6.4 North America Injectable Anthelmintic Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Injectable Anthelmintic Drugs Market Size (2020-2031)
7.2 Europe Injectable Anthelmintic Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Injectable Anthelmintic Drugs Market Size by Country (2020-2025)
7.4 Europe Injectable Anthelmintic Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Injectable Anthelmintic Drugs Market Size (2020-2031)
8.2 Asia-Pacific Injectable Anthelmintic Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Injectable Anthelmintic Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Injectable Anthelmintic Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Injectable Anthelmintic Drugs Market Size (2020-2031)
9.2 Latin America Injectable Anthelmintic Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Injectable Anthelmintic Drugs Market Size by Country (2020-2025)
9.4 Latin America Injectable Anthelmintic Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Injectable Anthelmintic Drugs Market Size (2020-2031)
10.2 Middle East & Africa Injectable Anthelmintic Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Injectable Anthelmintic Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Injectable Anthelmintic Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Injectable Anthelmintic Drugs Introduction
11.1.4 Novartis Revenue in Injectable Anthelmintic Drugs Business (2020-2025)
11.1.5 Novartis Recent Development
11.2 Cipla
11.2.1 Cipla Company Details
11.2.2 Cipla Business Overview
11.2.3 Cipla Injectable Anthelmintic Drugs Introduction
11.2.4 Cipla Revenue in Injectable Anthelmintic Drugs Business (2020-2025)
11.2.5 Cipla Recent Development
11.3 Sun Pharmaceutical Industries
11.3.1 Sun Pharmaceutical Industries Company Details
11.3.2 Sun Pharmaceutical Industries Business Overview
11.3.3 Sun Pharmaceutical Industries Injectable Anthelmintic Drugs Introduction
11.3.4 Sun Pharmaceutical Industries Revenue in Injectable Anthelmintic Drugs Business (2020-2025)
11.3.5 Sun Pharmaceutical Industries Recent Development
11.4 Amneal Pharmaceuticals
11.4.1 Amneal Pharmaceuticals Company Details
11.4.2 Amneal Pharmaceuticals Business Overview
11.4.3 Amneal Pharmaceuticals Injectable Anthelmintic Drugs Introduction
11.4.4 Amneal Pharmaceuticals Revenue in Injectable Anthelmintic Drugs Business (2020-2025)
11.4.5 Amneal Pharmaceuticals Recent Development
11.5 Zoetis
11.5.1 Zoetis Company Details
11.5.2 Zoetis Business Overview
11.5.3 Zoetis Injectable Anthelmintic Drugs Introduction
11.5.4 Zoetis Revenue in Injectable Anthelmintic Drugs Business (2020-2025)
11.5.5 Zoetis Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Details
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline Injectable Anthelmintic Drugs Introduction
11.6.4 GlaxoSmithKline Revenue in Injectable Anthelmintic Drugs Business (2020-2025)
11.6.5 GlaxoSmithKline Recent Development
11.7 Bayer
11.7.1 Bayer Company Details
11.7.2 Bayer Business Overview
11.7.3 Bayer Injectable Anthelmintic Drugs Introduction
11.7.4 Bayer Revenue in Injectable Anthelmintic Drugs Business (2020-2025)
11.7.5 Bayer Recent Development
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Injectable Anthelmintic Drugs Introduction
11.8.4 Merck Revenue in Injectable Anthelmintic Drugs Business (2020-2025)
11.8.5 Merck Recent Development
11.9 Boehringer Ingelheim International
11.9.1 Boehringer Ingelheim International Company Details
11.9.2 Boehringer Ingelheim International Business Overview
11.9.3 Boehringer Ingelheim International Injectable Anthelmintic Drugs Introduction
11.9.4 Boehringer Ingelheim International Revenue in Injectable Anthelmintic Drugs Business (2020-2025)
11.9.5 Boehringer Ingelheim International Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Injectable Anthelmintic Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Benzimidazoles
Table 3. Key Players of Piperazine
Table 4. Key Players of Imidazothiazole
Table 5. Key Players of Spiroindoles
Table 6. Key Players of Others
Table 7. Global Injectable Anthelmintic Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Injectable Anthelmintic Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Injectable Anthelmintic Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Injectable Anthelmintic Drugs Market Share by Region (2020-2025)
Table 11. Global Injectable Anthelmintic Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Injectable Anthelmintic Drugs Market Share by Region (2026-2031)
Table 13. Injectable Anthelmintic Drugs Market Trends
Table 14. Injectable Anthelmintic Drugs Market Drivers
Table 15. Injectable Anthelmintic Drugs Market Challenges
Table 16. Injectable Anthelmintic Drugs Market Restraints
Table 17. Global Injectable Anthelmintic Drugs Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Injectable Anthelmintic Drugs Market Share by Players (2020-2025)
Table 19. Global Top Injectable Anthelmintic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Anthelmintic Drugs as of 2024)
Table 20. Ranking of Global Top Injectable Anthelmintic Drugs Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Injectable Anthelmintic Drugs Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Injectable Anthelmintic Drugs, Headquarters and Area Served
Table 23. Global Key Players of Injectable Anthelmintic Drugs, Product and Application
Table 24. Global Key Players of Injectable Anthelmintic Drugs, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Injectable Anthelmintic Drugs Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Injectable Anthelmintic Drugs Revenue Market Share by Type (2020-2025)
Table 28. Global Injectable Anthelmintic Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Injectable Anthelmintic Drugs Revenue Market Share by Type (2026-2031)
Table 30. Global Injectable Anthelmintic Drugs Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Injectable Anthelmintic Drugs Revenue Market Share by Application (2020-2025)
Table 32. Global Injectable Anthelmintic Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Injectable Anthelmintic Drugs Revenue Market Share by Application (2026-2031)
Table 34. North America Injectable Anthelmintic Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Injectable Anthelmintic Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Injectable Anthelmintic Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Injectable Anthelmintic Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Injectable Anthelmintic Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Injectable Anthelmintic Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Injectable Anthelmintic Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Injectable Anthelmintic Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Injectable Anthelmintic Drugs Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Injectable Anthelmintic Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Injectable Anthelmintic Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Injectable Anthelmintic Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Injectable Anthelmintic Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Injectable Anthelmintic Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Injectable Anthelmintic Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 49. Novartis Company Details
Table 50. Novartis Business Overview
Table 51. Novartis Injectable Anthelmintic Drugs Product
Table 52. Novartis Revenue in Injectable Anthelmintic Drugs Business (2020-2025) & (US$ Million)
Table 53. Novartis Recent Development
Table 54. Cipla Company Details
Table 55. Cipla Business Overview
Table 56. Cipla Injectable Anthelmintic Drugs Product
Table 57. Cipla Revenue in Injectable Anthelmintic Drugs Business (2020-2025) & (US$ Million)
Table 58. Cipla Recent Development
Table 59. Sun Pharmaceutical Industries Company Details
Table 60. Sun Pharmaceutical Industries Business Overview
Table 61. Sun Pharmaceutical Industries Injectable Anthelmintic Drugs Product
Table 62. Sun Pharmaceutical Industries Revenue in Injectable Anthelmintic Drugs Business (2020-2025) & (US$ Million)
Table 63. Sun Pharmaceutical Industries Recent Development
Table 64. Amneal Pharmaceuticals Company Details
Table 65. Amneal Pharmaceuticals Business Overview
Table 66. Amneal Pharmaceuticals Injectable Anthelmintic Drugs Product
Table 67. Amneal Pharmaceuticals Revenue in Injectable Anthelmintic Drugs Business (2020-2025) & (US$ Million)
Table 68. Amneal Pharmaceuticals Recent Development
Table 69. Zoetis Company Details
Table 70. Zoetis Business Overview
Table 71. Zoetis Injectable Anthelmintic Drugs Product
Table 72. Zoetis Revenue in Injectable Anthelmintic Drugs Business (2020-2025) & (US$ Million)
Table 73. Zoetis Recent Development
Table 74. GlaxoSmithKline Company Details
Table 75. GlaxoSmithKline Business Overview
Table 76. GlaxoSmithKline Injectable Anthelmintic Drugs Product
Table 77. GlaxoSmithKline Revenue in Injectable Anthelmintic Drugs Business (2020-2025) & (US$ Million)
Table 78. GlaxoSmithKline Recent Development
Table 79. Bayer Company Details
Table 80. Bayer Business Overview
Table 81. Bayer Injectable Anthelmintic Drugs Product
Table 82. Bayer Revenue in Injectable Anthelmintic Drugs Business (2020-2025) & (US$ Million)
Table 83. Bayer Recent Development
Table 84. Merck Company Details
Table 85. Merck Business Overview
Table 86. Merck Injectable Anthelmintic Drugs Product
Table 87. Merck Revenue in Injectable Anthelmintic Drugs Business (2020-2025) & (US$ Million)
Table 88. Merck Recent Development
Table 89. Boehringer Ingelheim International Company Details
Table 90. Boehringer Ingelheim International Business Overview
Table 91. Boehringer Ingelheim International Injectable Anthelmintic Drugs Product
Table 92. Boehringer Ingelheim International Revenue in Injectable Anthelmintic Drugs Business (2020-2025) & (US$ Million)
Table 93. Boehringer Ingelheim International Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
Table 97. Authors List of This Report
List of Figures
Figure 1. Injectable Anthelmintic Drugs Picture
Figure 2. Global Injectable Anthelmintic Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Injectable Anthelmintic Drugs Market Share by Type: 2024 VS 2031
Figure 4. Benzimidazoles Features
Figure 5. Piperazine Features
Figure 6. Imidazothiazole Features
Figure 7. Spiroindoles Features
Figure 8. Others Features
Figure 9. Global Injectable Anthelmintic Drugs Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Injectable Anthelmintic Drugs Market Share by Application: 2024 VS 2031
Figure 11. Hospital Pharmacies Case Studies
Figure 12. Retail Pharmacies Case Studies
Figure 13. Online Pharmacies Case Studies
Figure 14. Veterinary Pharmacies Case Studies
Figure 15. Others Case Studies
Figure 16. Injectable Anthelmintic Drugs Report Years Considered
Figure 17. Global Injectable Anthelmintic Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 18. Global Injectable Anthelmintic Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 19. Global Injectable Anthelmintic Drugs Market Share by Region: 2024 VS 2031
Figure 20. Global Injectable Anthelmintic Drugs Market Share by Players in 2024
Figure 21. Global Top Injectable Anthelmintic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Anthelmintic Drugs as of 2024)
Figure 22. The Top 10 and 5 Players Market Share by Injectable Anthelmintic Drugs Revenue in 2024
Figure 23. North America Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. North America Injectable Anthelmintic Drugs Market Share by Country (2020-2031)
Figure 25. United States Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Canada Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Injectable Anthelmintic Drugs Market Share by Country (2020-2031)
Figure 29. Germany Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. France Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. U.K. Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Italy Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Russia Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Nordic Countries Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Injectable Anthelmintic Drugs Market Share by Region (2020-2031)
Figure 37. China Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Japan Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. South Korea Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. India Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Australia Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Injectable Anthelmintic Drugs Market Share by Country (2020-2031)
Figure 45. Mexico Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Brazil Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Injectable Anthelmintic Drugs Market Share by Country (2020-2031)
Figure 49. Turkey Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. UAE Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Novartis Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2020-2025)
Figure 53. Cipla Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2020-2025)
Figure 54. Sun Pharmaceutical Industries Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2020-2025)
Figure 55. Amneal Pharmaceuticals Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2020-2025)
Figure 56. Zoetis Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2020-2025)
Figure 57. GlaxoSmithKline Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2020-2025)
Figure 58. Bayer Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2020-2025)
Figure 59. Merck Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2020-2025)
Figure 60. Boehringer Ingelheim International Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global Injectable Anthelmintic Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Benzimidazoles
Table 3. Key Players of Piperazine
Table 4. Key Players of Imidazothiazole
Table 5. Key Players of Spiroindoles
Table 6. Key Players of Others
Table 7. Global Injectable Anthelmintic Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Injectable Anthelmintic Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Injectable Anthelmintic Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Injectable Anthelmintic Drugs Market Share by Region (2020-2025)
Table 11. Global Injectable Anthelmintic Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Injectable Anthelmintic Drugs Market Share by Region (2026-2031)
Table 13. Injectable Anthelmintic Drugs Market Trends
Table 14. Injectable Anthelmintic Drugs Market Drivers
Table 15. Injectable Anthelmintic Drugs Market Challenges
Table 16. Injectable Anthelmintic Drugs Market Restraints
Table 17. Global Injectable Anthelmintic Drugs Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Injectable Anthelmintic Drugs Market Share by Players (2020-2025)
Table 19. Global Top Injectable Anthelmintic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Anthelmintic Drugs as of 2024)
Table 20. Ranking of Global Top Injectable Anthelmintic Drugs Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Injectable Anthelmintic Drugs Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Injectable Anthelmintic Drugs, Headquarters and Area Served
Table 23. Global Key Players of Injectable Anthelmintic Drugs, Product and Application
Table 24. Global Key Players of Injectable Anthelmintic Drugs, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Injectable Anthelmintic Drugs Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Injectable Anthelmintic Drugs Revenue Market Share by Type (2020-2025)
Table 28. Global Injectable Anthelmintic Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Injectable Anthelmintic Drugs Revenue Market Share by Type (2026-2031)
Table 30. Global Injectable Anthelmintic Drugs Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Injectable Anthelmintic Drugs Revenue Market Share by Application (2020-2025)
Table 32. Global Injectable Anthelmintic Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Injectable Anthelmintic Drugs Revenue Market Share by Application (2026-2031)
Table 34. North America Injectable Anthelmintic Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Injectable Anthelmintic Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Injectable Anthelmintic Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Injectable Anthelmintic Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Injectable Anthelmintic Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Injectable Anthelmintic Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Injectable Anthelmintic Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Injectable Anthelmintic Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Injectable Anthelmintic Drugs Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Injectable Anthelmintic Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Injectable Anthelmintic Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Injectable Anthelmintic Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Injectable Anthelmintic Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Injectable Anthelmintic Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Injectable Anthelmintic Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 49. Novartis Company Details
Table 50. Novartis Business Overview
Table 51. Novartis Injectable Anthelmintic Drugs Product
Table 52. Novartis Revenue in Injectable Anthelmintic Drugs Business (2020-2025) & (US$ Million)
Table 53. Novartis Recent Development
Table 54. Cipla Company Details
Table 55. Cipla Business Overview
Table 56. Cipla Injectable Anthelmintic Drugs Product
Table 57. Cipla Revenue in Injectable Anthelmintic Drugs Business (2020-2025) & (US$ Million)
Table 58. Cipla Recent Development
Table 59. Sun Pharmaceutical Industries Company Details
Table 60. Sun Pharmaceutical Industries Business Overview
Table 61. Sun Pharmaceutical Industries Injectable Anthelmintic Drugs Product
Table 62. Sun Pharmaceutical Industries Revenue in Injectable Anthelmintic Drugs Business (2020-2025) & (US$ Million)
Table 63. Sun Pharmaceutical Industries Recent Development
Table 64. Amneal Pharmaceuticals Company Details
Table 65. Amneal Pharmaceuticals Business Overview
Table 66. Amneal Pharmaceuticals Injectable Anthelmintic Drugs Product
Table 67. Amneal Pharmaceuticals Revenue in Injectable Anthelmintic Drugs Business (2020-2025) & (US$ Million)
Table 68. Amneal Pharmaceuticals Recent Development
Table 69. Zoetis Company Details
Table 70. Zoetis Business Overview
Table 71. Zoetis Injectable Anthelmintic Drugs Product
Table 72. Zoetis Revenue in Injectable Anthelmintic Drugs Business (2020-2025) & (US$ Million)
Table 73. Zoetis Recent Development
Table 74. GlaxoSmithKline Company Details
Table 75. GlaxoSmithKline Business Overview
Table 76. GlaxoSmithKline Injectable Anthelmintic Drugs Product
Table 77. GlaxoSmithKline Revenue in Injectable Anthelmintic Drugs Business (2020-2025) & (US$ Million)
Table 78. GlaxoSmithKline Recent Development
Table 79. Bayer Company Details
Table 80. Bayer Business Overview
Table 81. Bayer Injectable Anthelmintic Drugs Product
Table 82. Bayer Revenue in Injectable Anthelmintic Drugs Business (2020-2025) & (US$ Million)
Table 83. Bayer Recent Development
Table 84. Merck Company Details
Table 85. Merck Business Overview
Table 86. Merck Injectable Anthelmintic Drugs Product
Table 87. Merck Revenue in Injectable Anthelmintic Drugs Business (2020-2025) & (US$ Million)
Table 88. Merck Recent Development
Table 89. Boehringer Ingelheim International Company Details
Table 90. Boehringer Ingelheim International Business Overview
Table 91. Boehringer Ingelheim International Injectable Anthelmintic Drugs Product
Table 92. Boehringer Ingelheim International Revenue in Injectable Anthelmintic Drugs Business (2020-2025) & (US$ Million)
Table 93. Boehringer Ingelheim International Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
Table 97. Authors List of This Report
List of Figures
Figure 1. Injectable Anthelmintic Drugs Picture
Figure 2. Global Injectable Anthelmintic Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Injectable Anthelmintic Drugs Market Share by Type: 2024 VS 2031
Figure 4. Benzimidazoles Features
Figure 5. Piperazine Features
Figure 6. Imidazothiazole Features
Figure 7. Spiroindoles Features
Figure 8. Others Features
Figure 9. Global Injectable Anthelmintic Drugs Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Injectable Anthelmintic Drugs Market Share by Application: 2024 VS 2031
Figure 11. Hospital Pharmacies Case Studies
Figure 12. Retail Pharmacies Case Studies
Figure 13. Online Pharmacies Case Studies
Figure 14. Veterinary Pharmacies Case Studies
Figure 15. Others Case Studies
Figure 16. Injectable Anthelmintic Drugs Report Years Considered
Figure 17. Global Injectable Anthelmintic Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 18. Global Injectable Anthelmintic Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 19. Global Injectable Anthelmintic Drugs Market Share by Region: 2024 VS 2031
Figure 20. Global Injectable Anthelmintic Drugs Market Share by Players in 2024
Figure 21. Global Top Injectable Anthelmintic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Anthelmintic Drugs as of 2024)
Figure 22. The Top 10 and 5 Players Market Share by Injectable Anthelmintic Drugs Revenue in 2024
Figure 23. North America Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. North America Injectable Anthelmintic Drugs Market Share by Country (2020-2031)
Figure 25. United States Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Canada Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Injectable Anthelmintic Drugs Market Share by Country (2020-2031)
Figure 29. Germany Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. France Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. U.K. Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Italy Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Russia Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Nordic Countries Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Injectable Anthelmintic Drugs Market Share by Region (2020-2031)
Figure 37. China Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Japan Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. South Korea Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. India Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Australia Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Injectable Anthelmintic Drugs Market Share by Country (2020-2031)
Figure 45. Mexico Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Brazil Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Injectable Anthelmintic Drugs Market Share by Country (2020-2031)
Figure 49. Turkey Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. UAE Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Novartis Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2020-2025)
Figure 53. Cipla Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2020-2025)
Figure 54. Sun Pharmaceutical Industries Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2020-2025)
Figure 55. Amneal Pharmaceuticals Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2020-2025)
Figure 56. Zoetis Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2020-2025)
Figure 57. GlaxoSmithKline Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2020-2025)
Figure 58. Bayer Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2020-2025)
Figure 59. Merck Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2020-2025)
Figure 60. Boehringer Ingelheim International Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232